Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment of severe newly diagnosed immune thrombocytopenia involving an alveolar hemorrhage with combination therapy consisting of romiplostim, rituximab and vincristine.
Okazuka K, Masuko M, Matsuo Y, Miyakoshi S, Tanaka T, Kozakai T, Kobayashi H, Fuse K, Shibasaki Y, Moriyama M, Takizawa J, Fuse I, Toba K, Furukawa T. Okazuka K, et al. Intern Med. 2013;52(11):1239-42. doi: 10.2169/internalmedicine.52.0080. Intern Med. 2013. PMID: 23728563 Free article.
Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.
Furukawa T, Kurasaki-Ida T, Masuko M, Tsukada N, Okazuka K, Sato N, Yano T, Abe T, Momoi A, Shibasaki Y, Higashimura M, Karimata K, Moriyama M, Kuroha T, Takizawa J, Toba K, Narita M, Fuse I, Takahashi M, Aizawa Y. Furukawa T, et al. Among authors: okazuka k. Int J Hematol. 2010 Jul;92(1):144-51. doi: 10.1007/s12185-010-0610-0. Epub 2010 Jun 9. Int J Hematol. 2010. PMID: 20533008 Clinical Trial.
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
Izumi N, Furukawa T, Sato N, Okazuka K, Tsukada N, Abe T, Yano T, Kurasaki T, Masuko M, Toba K, Takahashi M, Aizawa Y. Izumi N, et al. Among authors: okazuka k. Bone Marrow Transplant. 2007 Nov;40(9):875-80. doi: 10.1038/sj.bmt.1705834. Epub 2007 Aug 27. Bone Marrow Transplant. 2007. PMID: 17724440
Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation.
Abe T, Furukawa T, Masuko M, Sugimoto A, Okazuka K, Honma K, Fujimura T, Iguchi S, Nishi S, Ueno M, Nagahashi M, Watanabe G, Ajioka Y, Isahai N, Nagai K, Kazuyama Y, Aizawa Y. Abe T, et al. Among authors: okazuka k. Int J Hematol. 2009 Oct;90(3):421-425. doi: 10.1007/s12185-009-0416-0. Epub 2009 Sep 11. Int J Hematol. 2009. PMID: 19763745
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases.
Tsuchiyama J, Imajo K, Yoshino T, Nanba N, Toyota A, Yoshida C, Fujii K, Kondo E, Okazuka K, Hashimoto S, Toba K, Fuse I, Aizawa Y, Harada M, Tsubota T. Tsuchiyama J, et al. Among authors: okazuka k. Ann Hematol. 2002 Oct;81(10):588-92. doi: 10.1007/s00277-002-0526-8. Epub 2002 Oct 12. Ann Hematol. 2002. PMID: 12424541
CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigens.
Hashimoto S, Toba K, Tsuchiyama J, Abe T, Yano T, Momoi A, Okazuka K, Kanazawa N, Takahashi M, Aizawa Y. Hashimoto S, et al. Among authors: okazuka k. Leuk Res. 2002 Mar;26(3):289-95. doi: 10.1016/s0145-2126(01)00115-1. Leuk Res. 2002. PMID: 11792418
38 results